Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariaelena Pierobon

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Molecular & Cellular Proteomics : MCP|August 1, 2008
A portrait of tissue phosphoprotein stability in the clinical tissue procurement processVirginia Espina, Kirsten H Edmiston, Michael Heiby, et al.
Expert Review of Proteomics|March 1, 2014
Stratification of clear cell renal cell carcinoma by signaling pathway analysisMattia Cremona, Virginia Espina, Dario Caccia, et al.
Journal of the National Cancer Institute|March 25, 2015
Lung cancer prognosis before and after recurrence in a population-based settingDario Consonni, Mariaelena Pierobon, Mitchell H Gail, et al.
Journal of Proteome Research|February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapyJulia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
British Journal of Cancer|September 25, 2024
Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohortDeepika Prasad, Elisa Baldelli, Edik M Blais, et al.
Cell Cycle (Georgetown, Tex.)|July 10, 2024
Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imagingErika Parasido, Patricia Ribeiro, Ramesh M Chingle, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Oncotarget|October 16, 2015
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumorsElisa Baldelli, Guido Bellezza, Eric B Haura, et al.
Genes|September 28, 2021
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung AdenocarcinomasElisa Baldelli, Emna El Gazzah, John Conor Moran, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Vertical inhibition of the autophagy pathway impairs growth and enhances sensitivity to mTORC1 inhibition in pancreatic ductal adenocarcinomaMallory K Roach, Seamus E Degan, Jonathan M DeLiberty, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Molecular & Cellular Proteomics : MCP|August 1, 2008
A portrait of tissue phosphoprotein stability in the clinical tissue procurement processVirginia Espina, Kirsten H Edmiston, Michael Heiby, et al.
Expert Review of Proteomics|March 1, 2014
Stratification of clear cell renal cell carcinoma by signaling pathway analysisMattia Cremona, Virginia Espina, Dario Caccia, et al.
Journal of the National Cancer Institute|March 25, 2015
Lung cancer prognosis before and after recurrence in a population-based settingDario Consonni, Mariaelena Pierobon, Mitchell H Gail, et al.
Journal of Proteome Research|February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapyJulia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
British Journal of Cancer|September 25, 2024
Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohortDeepika Prasad, Elisa Baldelli, Edik M Blais, et al.
Cell Cycle (Georgetown, Tex.)|July 10, 2024
Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imagingErika Parasido, Patricia Ribeiro, Ramesh M Chingle, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Oncotarget|October 16, 2015
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumorsElisa Baldelli, Guido Bellezza, Eric B Haura, et al.
Genes|September 28, 2021
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung AdenocarcinomasElisa Baldelli, Emna El Gazzah, John Conor Moran, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Vertical inhibition of the autophagy pathway impairs growth and enhances sensitivity to mTORC1 inhibition in pancreatic ductal adenocarcinomaMallory K Roach, Seamus E Degan, Jonathan M DeLiberty, et al.
Pageof 10